Cargando…

Putative lung adenocarcinoma with epidermal growth factor receptor mutation presenting as carcinoma of unknown primary site: A case report

RATIONALE: Only a few cases of putative lung adenocarcinoma presenting as carcinoma of unknown primary site (CUP) with epidermal growth factor receptor (EGFR) mutation have been reported, and the efficacy of EGFR-tyrosine kinase inhibitors (TKIs) for these cases is unclear. PATIENT CONCERNS AND DIAG...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamasaki, Masahiro, Funaishi, Kunihiko, Saito, Naomi, Sakano, Ayaka, Fujihara, Megumu, Daido, Wakako, Ishiyama, Sayaka, Deguchi, Naoko, Taniwaki, Masaya, Ohashi, Nobuyuki, Hattori, Noboru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839817/ https://www.ncbi.nlm.nih.gov/pubmed/29443782 http://dx.doi.org/10.1097/MD.0000000000009942

Ejemplares similares

A Rare Combination of Dermatomyositis, Interstitial Pneumonia, and Lung Cancer in a Patient Treated with Immunosuppressive Therapy and Chemotherapy
por: Daido, Wakako, et al.
Publicado: (2017)

First-Line Treatment with Carboplatin plus nab-Paclitaxel and Maintenance Monotherapy with nab-Paclitaxel for a Thymic Carcinoma: A Case Report
por: Funaishi, Kunihiko, et al.
Publicado: (2017)

Platinum-doublet chemotherapy followed by pembrolizumab therapy for lung cancer with lymphangitis carcinomatosa mimicking interstitial pneumonitis: A case report
por: Yamasaki, Masahiro, et al.
Publicado: (2019)

Pulmonary cryptococcosis in a ruxolitinib-treated patient with primary myelofibrosis
por: Hirano, Anna, et al.
Publicado: (2017)

Acetylcholine receptor antibody-positive myasthenia gravis associated with small-cell lung cancer: A case report
por: Yamasaki, Masahiro, et al.
Publicado: (2018)

ROS1-rearranged putative lung adenocarcinoma presenting as carcinoma of unknown primary site: a case report
por: Taniwaki, Masaya, et al.
Publicado: (2018)

Nivolumab therapy for lung cancer with tracheo-parenchymal fistula: A case report
por: Yamasaki, Masahiro, et al.
Publicado: (2018)

Pericardial Effusion With Tamponade in Lung Cancer Patients During Treatment With Nivolumab: A Report of Two Cases
por: Yamasaki, Masahiro, et al.
Publicado: (2019)

A bronchial fibroepithelial polyp with abnormal findings on auto‐fluorescence imaging
por: Saito, Naomi, et al.
Publicado: (2017)

Nivolumab Therapy for Synchronous ALK-Positive Lung Cancer and Gastric Cancer
por: Yamasaki, Masahiro, et al.
Publicado: (2017)

Organizing pneumonia in a carrier of human T-cell lymphotropic virus type-1
por: Yamasaki, Masahiro, et al.
Publicado: (2020)

Smoldering adult T-cell leukemia complicated with pneumocystis pneumonia: A case report
por: Kawamoto, Kazuma, et al.
Publicado: (2021)

Reply to Takimoto: Micronodular Pattern of Organizing Pneumonia or Hypersensitivity Pneumonia Induced by an Immune Checkpoint Inhibitor?
por: Yamasaki, Masahiro, et al.
Publicado: (2020)

Small Cell Lung Cancer with Bizarre Radiographic Findings
por: Yamasaki, Masahiro, et al.
Publicado: (2018)

Multiple patchy pulmonary consolidation in granulomatosis with polyangiitis
por: Yamasaki, Masahiro, et al.
Publicado: (2020)

A Simple Risk Model to Predict Survival in Patients With Carcinoma of Unknown Primary Origin
por: Huang, Chen-Yang, et al.
Publicado: (2015)

Pancreatic carcinoma masked as fever of unknown origin: A case report and comprehensive review of literature
por: Shi, Ning, et al.
Publicado: (2016)

D-dimer can be a diagnostic marker for cisplatin-related aortic thrombosis: A case report
por: Matsumoto, Yu, et al.
Publicado: (2021)

Osteoblastic bone metastases from neuroendocrine tumor (NET) of unknown origin detected by (18)fluorocholine PET/CT and its comparison with (68)gallium-DOTATOC PET/CT: Case report and review of the literature
por: Bongiovanni, Alberto, et al.
Publicado: (2017)

Importance of Continuous Sequential Chemotherapy and Multimodal Treatment for Advanced Testicular Cancer: A High-Volume Japanese Center Experience
por: Nakamura, Terukazu, et al.
Publicado: (2015)

Phase II study of vincristine, actinomycin-D, cyclophosphamide and irinotecan for patients with newly diagnosed low-risk subset B rhabdomyosarcoma: A study protocol
por: Miyachi, Mitsuru, et al.
Publicado: (2019)

A phase 2 basket trial of combination therapy with trastuzumab and pertuzumab in patients with solid cancers harboring human epidermal growth factor receptor 2 amplification (JUPITER trial)
por: Takahashi, Kenta, et al.
Publicado: (2020)

Clinical and genetic diagnosis of Cowden syndrome: A case report of a rare PTEN germline variant and diverse clinical presentation
por: Arai, Hironori, et al.
Publicado: (2023)

Drug-related genetic polymorphisms affecting severe chemotherapy-induced neutropenia in breast cancer patients: A hospital-based observational study
por: Tsuji, Daiki, et al.
Publicado: (2016)

Rare clinical presentations of pleomorphic xanthoastrocytoma with a high proliferative index: Two case reports
por: Nagaishi, Masaya, et al.
Publicado: (2020)

Successful treatment with lorlatinib in a patient with meningeal carcinomatosis of ALK-positive non-small cell lung cancer resistant to alectinib and brigatinib: A case report
por: Nakashima, Koki, et al.
Publicado: (2021)

Expression of Human Epidermal Growth Factor Receptor-2 in Resected Rectal Cancer
por: Meng, Xiangjiao, et al.
Publicado: (2015)

Baseline, Trend, and Normalization of Carcinoembryonic Antigen as Prognostic Factors in Epidermal Growth Factor Receptor-Mutant Nonsmall Cell Lung Cancer Patients Treated With First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
por: Chen, Yu-Mu, et al.
Publicado: (2015)

Epidermal growth factor receptor-mutant pulmonary adenocarcinoma coexisting with tuberculosis: A case report
por: Liu, Ning, et al.
Publicado: (2021)

Hepatocellular carcinoma treated with anti-epidermal growth factor receptor antibody nimotuzumab: A case report
por: Song, Peng, et al.
Publicado: (2017)

Anti epidermal growth factor receptor therapy in small bowel adenocarcinoma: Case report and literature review
por: Falcone, Rosa, et al.
Publicado: (2018)

Association between polymorphisms of epidermal growth factor 61 and susceptibility of lung cancer: A meta-analysis
por: Chen, Quan, et al.
Publicado: (2020)

Epidermal growth factor receptor (EGFR) inhibitor induced purpuric drug eruption: Three case reports
por: Fang, Szu-Yun, et al.
Publicado: (2019)

Efficacy and safety of nanoparticle albumin-bound paclitaxel monotherapy as second-line therapy of cytotoxic anticancer drugs in patients with advanced non-small cell lung cancer
por: Anzai, Masaki, et al.
Publicado: (2017)

Liver Metastasis of a Triple-Negative Breast Cancer and Complete Remission for 5 Years After Treatment With Combined Bevacizumab/Paclitaxel/Carboplatin: Case Report and Review of the Literature
por: Ogata, Hideaki, et al.
Publicado: (2015)

Efficacy of epidermal growth factor receptor tyrosine kinase inhibitor in the treatment of patients with nonsmall cell lung cancer
por: Li, Xi, et al.
Publicado: (2023)

Gender-Based Impact of Epidermal Growth Factor Receptor Mutation in Patients With Nonsmall Cell Lung Cancer and Previous Tuberculosis
por: Chang, Chia-Hao, et al.
Publicado: (2015)

Is it feasible to detect epidermal growth factor receptor mutations in circulating tumor cells in nonsmall cell lung cancer?: A meta-analysis
por: Liu, Yafang, et al.
Publicado: (2016)

Lymphocyte percentage and platelet count correlate with the treatment outcome to tyrosine kinase inhibitors in epidermal growth factor receptor–mutated lung adenocarcinoma
por: Li, Chi-Cheng, et al.
Publicado: (2020)

Efficacy of nanoparticle albumin-bound paclitaxel regimens for relapsed small cell lung cancer: A retrospective analysis
por: Naito, Yujiro, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_t48m0jie5mfu5n48ra83au4i5n